CTLA4 and urogenital neoplasm: Next, we investigated whether blocking the CD28-B7 co-stimulation pathway using CTLA-4 Ig, a fusion protein currently used as maintenance therapy in kidney transplant recipients, in combination with IL2c would also promote allograft survival in our model.